Following U.S. Stocks are among the “Top Gainers” Stocks in the course of recent trading session, Friday: Prothena Corporation PLC (NASDAQ:PRTA), Vascular Biogenics Ltd (NASDAQ:VBLT), Envivio Inc (NASDAQ:ENVI), Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP)

Prothena Corporation PLC (NASDAQ:PRTA), stated positive results from a Phase 1 single ascending dose study of PRX002, a monoclonal antibody for the potential treatment of Parkinson`s disease and other related synucleinopathies. PRX002 is the focus of a worldwide partnershipbetween Prothena and Roche.

PRX002 was safe and well-tolerated, meeting the primary objective of the study. Further, results from this study showed that administration of PRX002 leads to mean reduction of free serum alpha-synuclein levels of up to 96%.

Prothena Corporation PLC (NASDAQ:PRTA)’s shares picked up 39.51%, and is now trading at $40.78. The Stock is active as 3.42M shares changed hands versus its average volume of 250,697.00 shares. The stock has price to sale ratio of 16.34, however, price to book ratio is 2.65. With recent incline, the year-to-date (YTD) performance reflected a 97.49% gain above last year. During the past month the stocks gain 48.47%, bringing three-month performance to 89.61% and six-month performance to 73.8%. The mean recommendation of analysts for this stock is 1.70. (where 1=Buy, 5=Sale).

Prothena Corporation plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of novel antibodies for the treatment of various diseases associated with protein misfolding or cell adhesion. Its product pipeline comprises NEOD001, a product candidate in Phase 1 clinical trial to target AL and AA forms of amyloidosis; PRX002 for the treatment of Parkinson’s disease and related synucleinopathies; and PRX003 for the treatment of inflammatory disease and metastatic cancers. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein. Prothena Corporation plc was incorporated in 2012 and is headquartered in Dublin, Ireland.

Vascular Biogenics Ltd (NASDAQ:VBLT), declared that it will host a conference call and live audio webcast on Wednesday, March 25, 2015 at 8:30 a.m. ET to report fourth quarter and full year 2014 financial results and talk about recent business activities.

Vascular Biogenics Ltd (NASDAQ:VBLT), raised 28.69%, and is now trading at $6.10. The Stock is active as 4.23M shares changed hands versus its average volume of 192,427.00 shares. The company holds the market capitalization of $120.81M. Its 20-day moving average gained 69.41%, below 50-day moving average of -28.10%, below 200-day moving average of -13.35% from the latest market price of $6.39. The mean recommendation of analysts for this stock is 2.70.(where 1=Buy, 5=Sale).

Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates comprise VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, in addition to VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.

Envivio Inc (NASDAQ:ENVI), stated financial results for the fourth quarter and fiscal year 2015 ending January 31, 2015.

Financial Highlights:

• Income for the fourth quarter of fiscal 2015 was $12.7 million, contrast with $9.0 million in the third quarter of fiscal 2015 and $12.5 million in the fourth quarter of fiscal 2014. Income for fiscal year 2015 was $41.6 million, contrast with $43.2 million in fiscal 2014.

• GAAP net loss for the fourth quarter of fiscal 2015 was $1.6 million, or $0.06 per share, contrast with a net loss of $5.4 million, or $0.20 per share, in the third quarter of fiscal 2015 and net loss of $2.0 million, or $0.08 per share, in the fourth quarter of fiscal 2014. GAAP net loss for fiscal 2015 was $15.6 million, or $0.57 per share, contrast with net loss of $12.2 million, or $0.45 per share in fiscal 2014.

• Non-GAAP net loss for the fourth quarter of fiscal 2015 was $0.5 million, or $0.02 per share. This is contrast with a net loss of $4.1 million, or $0.15 per share, in the third quarter of fiscal 2015 and net loss of $1.4 million, or $0.05 per share, in the fourth quarter of fiscal 2014. Non-GAAP net loss for fiscal 2015 was $13 million contrast with a net loss of $9.8 million in the prior year.

Envivio Inc (NASDAQ:ENVI), enhanced 31.18%, and is now trading at $2.02. The Stock is active as 1.52M shares changed hands versus its average volume of 43,620.00 shares. The stock volatility for the week is 10.62%, while for the month remained 7.03%.

If we consider EPS growth of the company, then the company indicated the following observations:

The company showed -0.59 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 37.50% and Annual EPS growth for the past 5 years is considered as 5.30%.

The mean recommendation of analysts for this stock is 3.00. (where 1=Buy, 5=Sale).

Envivio, Inc. provides software-based IP video processing and distribution solutions that enable the delivery of high-quality video to consumers worldwide. The company designs its solutions, based on its video compression and advanced IP video networking technologies, to enable service providers and content providers to offer high-quality video across various video formats, networks, consumer devices, and operating systems. Its suite of products comprises of Muse, a multi-screen software architecture designed for live or file-based video transcoding and distribution to various devices; Halo, a network media processor that performs content processing and adaptation for consumer devices; Guru, a network administration system to manage next generation video headends for mobile TV, OTT, and IPTV; and Envivio appliances, a software-based approach to video compression and media processing. The company also offers on-site project assessment, systems integration, on-site delivery, and operational and customer support services.

Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP), stated its unaudited financial results for the fourth quarter and the full year ended December 31, 2014.

Highlights for the Fourth Quarter of 2014:

• Net incomes were RMB1.9 billion (US$308 million) for the fourth quarter of 2014, up 33% year-on-year, surpassing our net income guidance of 30% raise year-on-year for the fourth quarter 2014.

• Accommodation reservation volume raised 53% year-on-year, surpassing our guidance of 40-50% volume raise year-on-year, and accommodation reservation incomes raised 31% year-on-year, reaching RMB842 million (US$136 million) for the fourth quarter of 2014.

• Transportation ticketing volume raised 102% year-on-year, surpassing our guidance of 55-65% volume raise year-on-year, and transportation ticketing incomes raised 34% year-on-year, reaching RMB774 million (US$125 million) for the fourth quarter of 2014.

• Gross margin was 69% for the fourth quarter of 2014, contrast to 73% in the same period in 2013, and 72% in the previous quarter.

Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP), rose 21.43%, and is now trading at $56.01. The Stock is active as 10.63M shares changed hands versus its average volume of 2.22M shares. The company has the market capitalization of $7.97B. The beta value of the stock is 0.97. On the other hand the stock’s volatility for the week is 3.60%, and for the month is 2.98%. The stock’s price to book ratio is 4.19, however price to sale ratio is 5.98. Analyst’s mean recommendation regarding this stock is 2.50. (where 1=Buy, 5=Sale).

Ctrip.com International, Ltd., together with its subsidiaries, provides travel services for hotel accommodations, ticketing services, packaged tours, and corporate travel administration in China. It also offers independent leisure travelers bundled packaged-tour products, counting group tours, semi-group tours, and private tours or packaged tours with various transportation arrangements, such as cruise, bus, or self-driving. In addition, the company provides integrated transportation and accommodation services; various value-added services, counting car rental, insurance, visa services, tour guides, transportation at destinations, and tickets; and supplier administration and customer relationship administration services. Further, it offers Internet-related advertising, aviation and train insurance, air-ticket delivery, online check-in, and online seat selection and flight dynamics services; and sells Property Administration System, a hotel information software, in addition to provides related maintenance services. Ctrip.com International, Ltd. was founded in 1999 and is headquartered in Shanghai, the People’s Republic of China.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.